Patent details

Basic Information

Publication number:

EP2779994

PCT Application Number:

US2012065011

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP127948305

PCT Publication Number:

WO2013074625

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

SUSPENSIONS OF CYCLOSPORIN A FORM 2

French Title of Invention:

SUSPENSIONS DE CYCLOSPORIN A FORM 2

German Title of Invention:

CYCLOSPORIN A FORM 2 SUSPENSIONEN

SPC Number:

Dates

Filing date:

14/11/2012

Grant date:

19/02/2020

EP Publication Date:

24/09/2014

PCT Publication Date:

23/05/2013

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

19/02/2020

EP B1 Publication Date:

19/02/2020

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

14/11/2020

Expiration date:

14/11/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

12/02/2020

 

 

Name:

ALLERGAN, INC.

Address:

2525 Dupont Drive, Irvine, CA 92612, United States (US)

Inventor

1

Name:

GORE, Anuradha V.

Address:

United States (US)

2

Name:

MOHANTY, Prem Swaroop

Address:

United States (US)

3

Name:

FARNES, E. Quinn

Address:

United States (US)

Priority

Priority Number:

201161559866 P

Priority Date:

15/11/2011

Priority Country:

United States (US)

Classification

IPC classification:

A61K 9/00;

Publication

European Patent Bulletin

1

Issue number:

202008

Publication date:

19/02/2020

Description:

Grant (B1)

2

Issue number:

202012

Publication date:

18/03/2020

Description:

Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages